Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin - Egyptian Knowledge Bank

41925

Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin

Thesis

Last updated: 06 Feb 2023

Overview Similar Items

Thesis

Fibroindex, a simple noninvasive test forprediction of fibrosis in patients withchronic hepatitis C virus infection

Thesis

Assessment of fibrosis biomarkers alone and incombination with tissue harmonic imaging versushistopathological fibrosis scoring in patients withchronic HCV infection and /or NASH

Thesis

Comparative study between liver biopsy versus fibroscan in chronic hepatitis C virus patients

Thesis

Evaluation of fibroscan as a predictor of risk of hepatocellular carcinoma in hepatitis C patients

Thesis

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C

Thesis

Non-invasive prediction of oesophageal varices with FibroScan and Doppler U/S in HCV patients with cirrhosis

Thesis

Evaluation of endoglin as a non–invasive marker of hepatic fibrosis in chronic hepatitis C patients

Thesis

Biochemical markers of liver fibrosis in HCV patients

Thesis

Towards a scoring system depending on laboratory and ultrasound findingsfor the detection of hepatic fibrosis in chronic HCV infected patients

Thesis

Role of transient elastography (fibroscan) in assessment of liver fibrosis in chronic hepatitis C patients